Loading…
PepGen Inc. is projected to rise to $1.86 by 2027, a +22% move from its current price of $1.52. PEPG is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.46 | $1.52 | $1.58 | -0.05% |
| May 30 | $1.43 | $1.52 | $1.61 | -0.10% |
| May 31 | $1.41 | $1.52 | $1.63 | -0.16% |
| Jun 1 | $1.40 | $1.52 | $1.65 | -0.21% |
| Jun 2 | $1.38 | $1.52 | $1.66 | -0.26% |
| Jun 3 | $1.37 | $1.52 | $1.68 | -0.31% |
| Jun 4 | $1.36 | $1.51 | $1.69 | -0.36% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.36 | $1.51 | $1.69 | -0.36% |
| Week 2 | $1.29 | $1.51 | $1.76 | -0.73% |
| Week 3 | $1.24 | $1.50 | $1.82 | -1.09% |
| Week 4 | $1.20 | $1.50 | $1.87 | -1.45% |
| Week 5 | $1.17 | $1.49 | $1.91 | -1.81% |
| Week 6 | $1.14 | $1.49 | $1.95 | -2.16% |
| Week 7 | $1.11 | $1.48 | $1.98 | -2.52% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
PepGen Inc. (PEPG) is a healthcare stock focused on developing oligonucleotide therapeutics. The company specializes in therapies for severe neuromuscular and neurologic diseases in the United States, including PGN-EDODM1, an EDO peptide-conjugated PMO in Phase 2 for myotonic dystrophy type 1, and FREEDOM2-DM1 in Phase 2 for the same condition, with FREEDOM-OLE as an open label expansion study.
PepGen was founded in 2018 and is based in Boston, Massachusetts. It operates within the Healthcare sector, pursuing clinical-stage biotechnology programs aimed at addressing unmet medical needs. The description reflects its focus on developing therapies and advancing clinical trials in its stated disease areas.
PepGen Inc. (PEPG) is a healthcare asset with a current price of $1.51, a market cap of $104.45M, and a rank of 4210. The stock trades within a 30-day range of $1.13 to $2.02, indicating a modest price channel in the near term.
Forecasts show a gradual uptrend in average prices over time, beginning near the current level and rising to a 2050 average of $4.78, with a 2050 max of $10.87. The early-year baseline (2026) is $1.51 on average, with a 0% ROI, and sentiment shifting to bullish in several later years (e.g., 2027–2030, 2033–2035, 2040, 2050). The 30-day range and volatility figure into the expected price trajectory, with a long-run bullish tilt.
A major floor 30.3% below — a decisive break under it would weaken the trend.
The nearest floor, 9.2% below — buyers have tended to step in here.
The nearest ceiling, 27.0% above — a clean break opens room to run.
A major ceiling 346.7% above — clearing it would confirm fresh momentum.
Key PEPG support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PEPG market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.51 | Buy | $1.52 | Buy |
| MA 10 | $1.54 | Sell | $1.55 | Sell |
| MA 20 | $1.64 | Sell | $1.66 | Sell |
| MA 50 | $2.28 | Sell | $2.40 | Sell |
| MA 100 | $4.07 | Sell | $3.25 | Sell |
| MA 200 | $4.03 | Sell | $3.71 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 36.66 | Neutral |
| Stoch RSI (14) | 82.54 | Sell |
| CCI (20) | -63.01 | Neutral |
| Williams %R (14) | -65.85 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | -13.64 | Sell |
| Bollinger %B (20,2) | 0.29 | Neutral |
| Stochastic %K (14) | 34.15 | Neutral |
| TRIX (15) | -1.77 | Sell |
| Awesome (5,34) | -0.13 | Sell |
| Ultimate (7,14,28) | 41.96 | Neutral |
| Momentum (10) | -0.16 | Sell |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 1.53 | Sell |
| ADX (14) | 35.11 | Sell |
| ATR (14) | 0.08 | Info |
Near-term the technical picture is neutral. RSI(14) is 40, and the price is below the SMA50 ($2.43) and far below the SMA200 ($4.03). This setup suggests limited upside momentum in the immediate term and potential downside risk if the price tests support.
Immediate support is at $1.38 and resistance at $1.93, framing a near-term trading range that includes the 30-day range, which spans from $1.13 to $2.02. The combination of neutral sentiment and the current position relative to key moving averages points to a watchful, range-bound near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.38 | $1.52 | $2.00 | 0% | Neutral | |
| $1.40 | $1.86 | $2.66 | +22% | Bullish | |
| $1.46 | $2.03 | $3.05 | +34% | Bullish | |
| $1.41 | $2.03 | $3.16 | +33% | Bullish | |
| $1.44 | $2.15 | $3.46 | +41% | Bullish | |
| $1.16 | $1.78 | $2.95 | +17% | Neutral | |
| $1.10 | $1.74 | $2.97 | +15% | Neutral | |
| $1.36 | $2.22 | $3.87 | +46% | Bullish | |
| $1.45 | $2.41 | $4.30 | +59% | Bullish | |
| $1.54 | $2.63 | $4.78 | +73% | Bullish | |
| $1.52 | $2.95 | $5.81 | +94% | Bullish | |
| $2.14 | $4.75 | $10.49 | +212% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.38 | $1.52 | $1.80 | +0.00% |
| June 2026 | $1.29 | $1.54 | $1.88 | +1.00% |
| July 2026 | $1.20 | $1.45 | $1.81 | -5.59% |
| August 2026 | $1.17 | $1.43 | $1.81 | -1.55% |
| September 2026 | $1.24 | $1.52 | $1.95 | +6.32% |
| October 2026 | $1.24 | $1.53 | $1.99 | +1.13% |
| November 2026 | $1.19 | $1.47 | $1.93 | -3.89% |
| December 2026 | $1.21 | $1.51 | $2.00 | +2.36% |
Click any year to see its month-by-month PEPG forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
PepGen Inc.'s 2026 outlook centres on $1.52, within a $1.38 to $2.00 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, PEPG could reach as high as $2.66, with a base case around $1.86 and support toward $1.40 — roughly +22% from $1.52. Momentum favours further upside here.
Expect PEPG to range from $1.46 to $3.05 through 2028. The $2.03 average target implies a +34% move from current prices. That is up +9% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The PEPG price prediction for 2029 points to an average of $2.03 (low $1.41, high $3.16) — a potential gain of +33% on today's $1.52. Momentum favours further upside here.
In 2030, PEPG is projected to trade between $1.44 and $3.46, averaging $2.15 — a potential gain of +41% from today's $1.52. That is up +6% on the projected 2029 average. Buyers look set to stay in control over this stretch.
PepGen Inc.'s 2031 outlook centres on $1.78, within a $1.16 to $2.95 range. That is -17% versus the projected 2030 average. That marks a +17% change versus current levels. Price action looks broadly range-bound.
By 2032, PEPG could reach as high as $2.97, with a base case around $1.74 and support toward $1.10 — roughly +15% from $1.52. A consolidation phase looks the most probable path here.
Expect PEPG to range from $1.36 to $3.87 through 2033. The $2.22 average target implies a +46% move from current prices. That is up +27% on the projected 2032 average. Momentum favours further upside here.
The PEPG price prediction for 2034 points to an average of $2.41 (low $1.45, high $4.30) — a potential gain of +59% on today's $1.52. Buyers look set to stay in control over this stretch.
In 2035, PEPG is projected to trade between $1.54 and $4.78, averaging $2.63 — a potential gain of +73% from today's $1.52. That is up +9% on the projected 2034 average. Momentum favours further upside here.
PepGen Inc.'s 2040 outlook centres on $2.95, within a $1.52 to $5.81 range. That is up +12% on the projected 2035 average. That marks a +94% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, PEPG could reach as high as $10.49, with a base case around $4.75 and support toward $2.14 — roughly +212% from $1.52. Momentum favours further upside here.
Investing $1,000 in PEPG today (≈ 657.894737 PEPG) could be worth
$3,122.88
+$2,122.88 (+212%) by 2050 · US Dollar
Based on the average projected PEPG price of $4.75 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PEPGwould be worth at today's price.
$1,000 invested in PEPG on May 27, 2025 (≈ 680.272096 PEPG) would be worth
$1,034.01
+$34.01 (+3.4%) today · 1.03× · US Dollar
Based on a PEPG entry price of $1.47 vs. today's $1.52.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.44 | $1,055.56 | +5.6% |
| 1 month ago | $1.6 | $950 | -5.0% |
| 3 months ago | $6.24 | $243.59 | -75.6% |
| 6 months ago | $6.44 | $236.02 | -76.4% |
| 1 year ago | $1.47 | $1,034.01 | +3.4% |
| All time (4.1y) ago | $12.89 | $117.92 | -88.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PEPG forecast.
Our base-case forecast reaches $3.00 around 2050.
Implied market cap at $3.00: $207.51M
The multi-year forecast shows a bullish tilt in several years, with the 2027 average price at $1.84 and the 2030 average at $2.15, rising to an average of $4.78 by 2050. The max forecasts reach $3.53 in 2030 and as high as $10.87 by 2050, with an overall 2050 return of 216.7%. The forecast includes 2026 at an average of $1.51 (ROI 0%) and 2028–2035 showing rising averages and positive ROIs, with sentiment turning bullish in multiple years (e.g., 2027, 2028, 2029, 2033–2035, 2040).
Volatility remains high, as indicated by an annualized volatility of 80%.
In practical terms, the outlook envisions a path from modest current levels toward substantially higher averages by mid-century, with several year-by-year upticks. However, the profile also shows intermittent neutral periods and notable volatility, underscoring that these are estimates rather than guarantees and that outcomes depend on market, clinical, and regulatory developments.
Tap a question to reveal the answer.
In 2030 the forecast shows an average price of $2.15, with a min of $1.42 and a max of $3.53. The return is projected at 42.5% and the sentiment is BULLISH.
The forecast includes multiple bullish years (e.g., 2027, 2028, 2029, 2033–2035, 2040, 2050) with rising averages and ROIs up to 216.7% by 2050; note that 2026 is flat at an average of $1.51 and the path includes periods of lower momentum and higher volatility.
Yes. The 2040 max forecast is $5.89, indicating a possibility of surpassing $5 by 2040.
The current price is $1.51. The 30-day range runs from a low of $1.13 to a high of $2.02.
The 2050 forecast shows an average price of $4.78, a min of $2.15, and a max of $10.87, with a return of 216.7% and bullish sentiment.
PepGen Inc. Community Discussion
0Share your PepGen Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.